Perinatal screening for group B streptococci: Cost-benefit analysis of rapid polymerase chain reaction

Pediatrics

Volumn 110, Issue 3, 2002, Pages 471-480

  Haberland, Corinna A ^a   Benitz, William E ^a   Sanders, Gillian D ^a   Pietzsch, Jan Benjamin ^b   Yamada, Sanae ^c   Nguyen, Lan ^c   Garber, Alan M ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford University   (United States)

^c STANFORD UNIVERSITY   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Cost benefit analysis; Mass screening; Streptococcal infections; Streptococcus agalactiae

Indexed keywords

ADULT; ANALYTIC METHOD; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD DEATH; COST BENEFIT ANALYSIS; DECISION MAKING; DISABILITY; EVALUATION; FEMALE; FETUS; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; INFANT DISEASE; NEWBORN; NORMAL HUMAN; PERINATAL CARE; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

COST-BENEFIT ANALYSIS; DECISION TREES; DELIVERY, OBSTETRIC; FEMALE; HUMANS; INFANT, NEWBORN; LABOR, OBSTETRIC; MASS SCREENING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0036728669     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.3.471     Document Type: Article

References (57)

1. Group B streptococcal infections
2. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
3. Early-onset group B streptococcal disease - United States, 1998-1999
4. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
5. Perinatal group B streptococcal colonization and infection
6. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis
7. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis
8. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test
9. Prevention of neonatal group B streptococcal disease: Intrapartum detection and chemoprophylaxis of heavily colonized parturients
10. Intra-partum chemoprophylaxis of early-onset group B streptococcal disease
11. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis
12. Prevention of perinatal group B streptococcal disease: A public health perspective
13. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection
14. ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173-June 1996
15. Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization
16. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis
17. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis
18. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection
19. Preventing early-onset group B streptococcal sepsis: Strategy development using decision analysis
20. Preventing neonatal group B streptococcal disease: Cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics
21. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery
22. Risk factors for early-onset group B streptococcal sepsis: Estimation of odds ratios by critical literature review
23. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers
24. Neonatal group B streptococcal infection in a managed care population
25. Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease
26. Effect of a screening-based prevention policy on prevalence of early-onset group B streptococcal sepsis
27. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants
28. Rapid detection of group B streptococci in pregnant women at delivery
29. The economic value of human life
30. Sequelae of early-onset group B hemolytic streptococcal neonatal meningitis
31. Long-term sequelae of group B streptococcal meningitis in infants
32. Long-term outcome of group B streptococcal meningitis
33. Early onset neonatal group B streptococcal infection: Prematurity predicts outcome
34. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures
35. Rectal colonization with group B streptococcus: Relation to vaginal colonization of pregnant women
36. Neonatal group B streptococcal sepsis during 2 years of a universal screening program
37. Group B beta haemolytic streptococci in the female genital tract: A study of four clinic populations
38. Anorectal and vaginal carriage of group B streptococci during pregnancy
39. Direct detection of group B streptococci from vaginal specimens compared with quantitative culture
40. Epidemiology of group B streptococcus: Longitudinal observations during pregnancy
41. Use of a DNA probe for the rapid detection of group B streptococci in obstetric patients
42. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale
43. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease
44. Maternal fever during labor - What does it mean?
45. Group B streptococcal carriage and disease: A 6-year prospective study
46. Colonization with group B streptococci in pregnancy and adverse outcome
47. Antimicrobial prevention of early-onset group B streptococcal sepsis: Estimates of risk reduction based on a critical literature review
48. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease
49. Births: Preliminary data for 1999
50. United States Life Tables, 1998
51. Costs and benefits of prenatal screening for cystic fibrosis
52. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus